Contact this trialFirst, we need to learn more about you.
Vasopressin V2 Receptor Antagonist
Tolvaptan IR +1 More for Polycystic Kidney Disease
Recruiting2 awardsPhase 2
Peoria, Arizona
The purpose of this study is to compare the short-term effects of two tolvaptan formulations in patients with ADPKD.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service